Floatz logo

Cipralex

Periampullary Cancer

Case Comprehensive Cancer CenterPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Periampullary Cancer cohort.

Asset / SponsorPhaseRating
HUMAN FIBRINOGEN
Asan Medical Center
Phase 4BB
N-BUTYL CYANOACRYLATE
Minia University
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
New Mexico Cancer Research Alliance
Phase 2CCC
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 2CCC

View all 12 →

Same molecule, other indications

Cipralex is also rated in:

Anxiety DisordersDormant
A
Indicative ·
81 / 100
View asset →
bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
dysthymic disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →